Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288059207> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4288059207 endingPage "6" @default.
- W4288059207 startingPage "1" @default.
- W4288059207 abstract "Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a serious adverse event of bone resorption inhibitors (BRIs), such as zoledronic acid and denosumab. Based on the results of phase 3 clinical trials for BRIs, the frequency of ARONJ is 1 to 2%, but the actual frequency is presumed to be higher. We studied 143 patients with urologic cancers with bone metastases who were treated with zoledronic acid or denosumab at our hospital between April 2007 and March 2020. ARONJ occurred in 24 patients (16.8%) ; that is, 14 of the 113 patients (12.4%) who received zoledronic acid alone, 8 of the 24 patients (33.3%) who received denosumab alone, and 2 of the 6 patients (33.3%) who sequentially switched from zoledronic acid to denosumab. ARONJ was cured in 8 patients (33.3%), improved in 3 patients (12.5%), unchanged in 4 patients (16.7%), and worsened in 9 patients (37.5%). The frequency of ARONJ increased as the duration of BRI administration prolonged. Time-to-ARONJ was shorter in patients treated with denosumab than in patients treated with zoledronic acid. The occurrence of ARONJ may be underestimated; therefore, further studies are needed to investigate the actual frequency of ARONJ in Japan." @default.
- W4288059207 created "2022-07-28" @default.
- W4288059207 creator A5002490706 @default.
- W4288059207 creator A5003687882 @default.
- W4288059207 creator A5013917805 @default.
- W4288059207 creator A5022608953 @default.
- W4288059207 creator A5027492101 @default.
- W4288059207 creator A5053810379 @default.
- W4288059207 creator A5061030859 @default.
- W4288059207 creator A5063408528 @default.
- W4288059207 creator A5064029070 @default.
- W4288059207 creator A5079589691 @default.
- W4288059207 date "2022-01-01" @default.
- W4288059207 modified "2023-10-16" @default.
- W4288059207 title "[Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers]." @default.
- W4288059207 doi "https://doi.org/10.14989/actauroljap_68_1_1" @default.
- W4288059207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35114759" @default.
- W4288059207 hasPublicationYear "2022" @default.
- W4288059207 type Work @default.
- W4288059207 citedByCount "0" @default.
- W4288059207 crossrefType "journal-article" @default.
- W4288059207 hasAuthorship W4288059207A5002490706 @default.
- W4288059207 hasAuthorship W4288059207A5003687882 @default.
- W4288059207 hasAuthorship W4288059207A5013917805 @default.
- W4288059207 hasAuthorship W4288059207A5022608953 @default.
- W4288059207 hasAuthorship W4288059207A5027492101 @default.
- W4288059207 hasAuthorship W4288059207A5053810379 @default.
- W4288059207 hasAuthorship W4288059207A5061030859 @default.
- W4288059207 hasAuthorship W4288059207A5063408528 @default.
- W4288059207 hasAuthorship W4288059207A5064029070 @default.
- W4288059207 hasAuthorship W4288059207A5079589691 @default.
- W4288059207 hasConcept C120665830 @default.
- W4288059207 hasConcept C121332964 @default.
- W4288059207 hasConcept C126322002 @default.
- W4288059207 hasConcept C126894567 @default.
- W4288059207 hasConcept C141071460 @default.
- W4288059207 hasConcept C143998085 @default.
- W4288059207 hasConcept C197934379 @default.
- W4288059207 hasConcept C2776286101 @default.
- W4288059207 hasConcept C2776326535 @default.
- W4288059207 hasConcept C2776541429 @default.
- W4288059207 hasConcept C2777251235 @default.
- W4288059207 hasConcept C2777556957 @default.
- W4288059207 hasConcept C61511704 @default.
- W4288059207 hasConcept C673006 @default.
- W4288059207 hasConcept C71924100 @default.
- W4288059207 hasConceptScore W4288059207C120665830 @default.
- W4288059207 hasConceptScore W4288059207C121332964 @default.
- W4288059207 hasConceptScore W4288059207C126322002 @default.
- W4288059207 hasConceptScore W4288059207C126894567 @default.
- W4288059207 hasConceptScore W4288059207C141071460 @default.
- W4288059207 hasConceptScore W4288059207C143998085 @default.
- W4288059207 hasConceptScore W4288059207C197934379 @default.
- W4288059207 hasConceptScore W4288059207C2776286101 @default.
- W4288059207 hasConceptScore W4288059207C2776326535 @default.
- W4288059207 hasConceptScore W4288059207C2776541429 @default.
- W4288059207 hasConceptScore W4288059207C2777251235 @default.
- W4288059207 hasConceptScore W4288059207C2777556957 @default.
- W4288059207 hasConceptScore W4288059207C61511704 @default.
- W4288059207 hasConceptScore W4288059207C673006 @default.
- W4288059207 hasConceptScore W4288059207C71924100 @default.
- W4288059207 hasIssue "1" @default.
- W4288059207 hasLocation W42880592071 @default.
- W4288059207 hasOpenAccess W4288059207 @default.
- W4288059207 hasPrimaryLocation W42880592071 @default.
- W4288059207 hasRelatedWork W10914099 @default.
- W4288059207 hasRelatedWork W12087825 @default.
- W4288059207 hasRelatedWork W14860905 @default.
- W4288059207 hasRelatedWork W15495912 @default.
- W4288059207 hasRelatedWork W17726481 @default.
- W4288059207 hasRelatedWork W19451935 @default.
- W4288059207 hasRelatedWork W278444 @default.
- W4288059207 hasRelatedWork W5984520 @default.
- W4288059207 hasRelatedWork W6940751 @default.
- W4288059207 hasRelatedWork W9968723 @default.
- W4288059207 hasVolume "68" @default.
- W4288059207 isParatext "false" @default.
- W4288059207 isRetracted "false" @default.
- W4288059207 workType "article" @default.